HSD17B3
Basic information
Region (hg38): 9:96235306-96302176
Links
Phenotypes
GenCC
Source:
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency (Strong), mode of inheritance: AR
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency (Supportive), mode of inheritance: AR
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| 17-Beta hydroxysteroid dehydrogenase III deficiency | AR | Endocrine; Genitourinary | Prepubertal diagnosis may allow surgical treatment via removal of abnormal testes, preventing typical presenting clinical signs in puberty (marked masculinization and hirsutism) | Endocrine; Genitourinary | 2998649; 8075637; 8550739; 10599740; 21700882; 22212252; 22594312; 22445608; 22876557 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (237 variants)
- Testosterone_17-beta-dehydrogenase_deficiency (63 variants)
- Inborn_genetic_diseases (25 variants)
- Pseudohermaphroditism (13 variants)
- not_specified (9 variants)
- HSD17B3-related_disorder (9 variants)
- Disorder_of_sexual_differentiation (2 variants)
- Sex_development_disorder (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HSD17B3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000197.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 71 | 74 | ||||
| missense | 17 | 44 | 74 | |||
| nonsense | 9 | |||||
| start loss | 3 | 3 | ||||
| frameshift | 13 | |||||
| splice donor/acceptor (+/-2bp) | 14 | |||||
| Total | 28 | 33 | 50 | 74 | 2 |
Highest pathogenic variant AF is 0.0006124633
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| HSD17B3 | protein_coding | protein_coding | ENST00000375263 | 11 | 66847 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 8.49e-7 | 0.760 | 125713 | 0 | 35 | 125748 | 0.000139 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.367 | 155 | 168 | 0.920 | 0.00000966 | 2001 |
| Missense in Polyphen | 49 | 53.89 | 0.90927 | 664 | ||
| Synonymous | 0.568 | 63 | 69.0 | 0.913 | 0.00000446 | 613 |
| Loss of Function | 1.28 | 12 | 17.8 | 0.673 | 7.76e-7 | 219 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000289 | 0.0000289 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.000508 | 0.000508 |
| European (Non-Finnish) | 0.000150 | 0.000149 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.000131 | 0.000131 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Favors the reduction of androstenedione to testosterone. Uses NADPH while the two other EDH17B enzymes use NADH. {ECO:0000269|PubMed:26545797}.;
- Pathway
- Steroid hormone biosynthesis - Homo sapiens (human);17-Beta Hydroxysteroid Dehydrogenase III Deficiency;Androgen and Estrogen Metabolism;Aromatase deficiency;Androgen Receptor Network in Prostate Cancer;Steroid Biosynthesis;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Metabolism;Fatty acid metabolism;Androgen biosynthesis;Metabolism of steroid hormones;Metabolism of steroids;androgen biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;superpathway of steroid hormone biosynthesis;Steroid hormones
(Consensus)
Recessive Scores
- pRec
- 0.219
Intolerance Scores
- loftool
- 0.229
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 42.06
Haploinsufficiency Scores
- pHI
- 0.122
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0330
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hsd17b3
- Phenotype
Gene ontology
- Biological process
- steroid biosynthetic process;androgen biosynthetic process;male genitalia development;oxidation-reduction process;testosterone biosynthetic process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;intracellular membrane-bounded organelle
- Molecular function
- testosterone dehydrogenase [NAD(P)] activity;testosterone 17-beta-dehydrogenase (NADP+) activity